Parkinson's disease is a neurodegenerative disorder that is usually diagnosed in its late stage on the basis of clinical ...

Scientists are looking for answers about how these confounding trips, known as metastases, occur throughout the human body ...

Researchers at Ruhr University Bochum and betaSENSE identified a biomarker in spinal fluid that detects early-stage Parkinson’s disease with over 90% sensitivity and specificity. This offers a ...

AMX0114 is an antisense oligonucleotide made to prevent or slow the degeneration of axons, which is a key driver of ALS ...

Patients will be randomized to receive two doses of study drug or placebo (cerebro-spinal fluid without stem cells). A cryopreservation procedure will be developed so that ALS patients do not have ...

The team conducted a spinal tap to analyze the patients' cerebral spinal fluid. What came back was ... her CD320 ...

The CAR T-cell therapy KYV-101 is safe, and showed preliminary signs of efficacy in patients with progressive forms of MS in ...

One form of immunotherapy, called CAR-T-cell therapy, uses genetic engineering ... The research team identified 864 proteins ...

Arvinas, Inc. (NASDAQ:ARVN) unveiled first-in-human data on Friday for its experimental Parkinson’s disease treatment, ARV-102. Results from the randomized, double-blind, placebo-controlled single ...

Damage to these cells leads to capillary damage ... and three membranes surrounding the brain and spinal cord. Meningitis can occur when fluid surrounding these membranes becomes infected.

Outside of the cell, tau forms what scientists call phosphorylated ... first test for this crystalized form of tau, but in the spinal fluid. Because of the inconvenience and risk of spinal taps ...